Upgrade to SI Premium - Free Trial

Marker Therapeutics (MRKR)

1.42 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/13/26)

Latest Headlines

H.C. Wainwright Reiterates Buy Rating on Marker Therapeutics (MRKR) May 20, 2026 6:49 AM - StreetInsider Form 10-Q Marker Therapeutics, For: Mar 31 May 15, 2026 5:01 PM - SEC Filing Form 8-K Marker Therapeutics, For: May 01 May 4, 2026 4:31 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Marker Therapeutics (MRKR) March 23, 2026 6:48 AM - StreetInsider Form DEFA14A Marker Therapeutics, March 20, 2026 4:09 PM - SEC Filing Form ARS Marker Therapeutics, For: Dec 31 March 20, 2026 4:08 PM - SEC Filing Form DEF 14A Marker Therapeutics, For: May 01 March 20, 2026 4:06 PM - SEC Filing Form 8-K Marker Therapeutics, For: Mar 18 March 19, 2026 6:01 AM - SEC Filing Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results March 18, 2026 5:31 PM - Globe NewsWire Form 10-K Marker Therapeutics, For: Dec 31 March 18, 2026 5:27 PM - SEC Filing Form PRE 14A Marker Therapeutics, For: May 01 March 10, 2026 5:00 PM - SEC Filing Full Article List